PPT-USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE

Alfonso Iorio McMaster University Canada Disclosures Financial No relevant relationships to disclose Research funding in the field of hemophilia care Intellectual Faculty at McMaster University. Our aim is to promote active particip ation in your care and treatment by providing information and education Questions about individual health concerns or specific treatment options should be discussed with your physician 2011 The Regents of the Un Current Controversies in Hematology and Oncology he cost of cancer drugs is at an all-time high, with several lifesaving agents costing more than $100,000 a year. Much of the discussion related to hea Maria Proytcheva, MD. University of Arizona. Banner University Medical Center-Tucson, USA. Financial Disclosure. The author has no conflict of interest to disclose. Do the Current Practices of Developing Neonatal Reference Intervals Meet Clinical Need?. Susan . Claster. MD. Division of Hematology Oncology. UCI Medical Center. Thank you. What is Benign Hematology?. Clotting/thrombophilia. Bleeding disorders. Hemoglobinopathies. Non malignant disorders of . . . Laboratory . Organizational . Divisions:. . . Anatomical. Responsible for the analysis of tissues from the body including surgical specimens, frozen sections, biopsies, cytological specimens & autopsies. . Immune Deficiencies . Bruton. . Agammaglobulinemia. X-Linked Recessive. Occurs MC in males . Infections start at . 6-9. . months. Can see multiple:. Ear infections . Diarrheal episodes. Pneumonias . Russ Nassof, JD. RiskNomics, LLC. Disclosures . Russ Nassof is a paid consultant/speaker . for Becton Dickinson (BD). Russ Nassof is the owner of RiskNomics, . a consulting company.. 2. Objectives. Understand the difference between clinical practice guidelines (CPGs) and evidence based medicine (EBM) and their effect on current practice and policies.. , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. UNC and Chapel Hill. UNC. Oldest public university in the US. NCI-ranked “Exceptional” Comprehensive Cancer Center . Gillings. School of Public Health (#2 in U.S.). Eshelman. School of Pharmacy (#1 in U.S.). Alice J. Cohen, M.D., F.A.C.P.. Newark Beth Israel Medical Center. Associate Clinical Professor of Medicine. Rutgers - New Jersey Medical School. Newark, NJ. Disclosures. None. Scope of the Problem. Barbara A. Konkle, M.D.. Medical Director, Hemostasis Reference Laboratory. Puget Sound Blood Center. Professor of Medicine/Hematology. University of Washington. Seattle, WA. Disclosures. Nothing to disclose. ARC Jour Volume 4 , Issue 2, 2019, PP 1 - 4 www.arcjournals.org ARC Journal of Hematology Page | 1 Difficulties Diagnostic of Amegacaryocytic Thrombocytopenic Purpura in Developing Country: A Case Welcome to the Oncology Clinic In the following pages, we will help you with: hat to expect at your first visit ow to get to the Hematology/Oncology Clinicow to make the most of your appointmentWe kindly visit us at www.nexancourse.com. Prepare your certification exams with real time Certification Questions & Answers verified by experienced professionals! We make your certification journey easier as we provide you learning materials to help you to pass your exams from the first try.